Elisabeth Minder

Elisabeth Minder

UNVERIFIED PROFILE

Are you Elisabeth Minder?   Register this Author

Register author
Elisabeth Minder

Elisabeth Minder

Publications by authors named "Elisabeth Minder"

Are you Elisabeth Minder?   Register this Author

43Publications

726Reads

22Profile Views

Delta-aminolevulinic acid synthase 2 expression in combination with iron as modifiers of disease severity in erythropoietic protoporphyria.

Mol Genet Metab 2019 11 2;128(3):304-308. Epub 2019 May 2.

Institute of Laboratory Medicine, Municipal Hospital Triemli, Zürich, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymgme.2019.04.013DOI Listing
November 2019

A next-generation-sequencing panel for mutational analysis of dominant acute hepatic porphyrias.

Scand J Clin Lab Invest 2019 Sep 1;79(5):305-313. Epub 2019 Jun 1.

a Institute of Laboratory Medicine, Triemli Hospital , Zurich , Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00365513.2019.1622030DOI Listing
September 2019

[Porphyria - when to think about how to clarify and treat?]

Ther Umsch 2018 Nov;75(4):225-233

1 Schweizerisches Versorgungsnetzwerk für Porphyrie c / o Stadtspital Triemli, Abteilung für Endokrinologie, Diabetologie und Porphyrie, Zürich.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1024/0040-5930/a000993DOI Listing
November 2018

CME-Antworten.

Praxis (Bern 1994) 2018 Feb;107(4):229-230

3 Porphyrie-Sprechstunde, Ambulantes Perioperatives Zentrum (APZ), Stadtspital Triemli Zürich.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1024/1661-8157/a002888DOI Listing
February 2018

[CME: Acute Intermittent Porphyria: When to Think of It? What Must be Checked? How to Treat?]

Praxis (Bern 1994) 2018 Jan;107(3):117-124

3 Porphyrie-Sprechstunde, Ambulantes Perioperatives Zentrum (APZ), Stadtspital Triemli Zürich.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1024/1661-8157/a002887DOI Listing
January 2018

Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders.

Clin Pharmacokinet 2017 08;56(8):815-823

Stadtspital Triemli, Institute of Laboratory Medicine, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40262-016-0501-5DOI Listing
August 2017

Iron and erythropoietic porphyrias.

Blood 2015 Jul;126(2):130-2

STADTSPITAL TRIEMLI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-05-646737DOI Listing
July 2015

Biallelic inactivation of protoporphyrinogen oxidase and hydroxymethylbilane synthase is associated with liver cancer in acute porphyrias.

J Hepatol 2015 Mar 28;62(3):734-8. Epub 2014 Nov 28.

Department of Dermatology, Maastricht University Medical Center (MUMC), The Netherlands; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center (MUMC), The Netherlands; Department of Dermatology and Skin Cancer Center and European Porphyria Specialist Center, Medical Faculty of the Heinrich Heine University, Düsseldorf, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2014.11.029DOI Listing
March 2015

In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability.

Blood Cells Mol Dis 2015 Jan 30;54(1):71-7. Epub 2014 Aug 30.

Institute of Laboratory Medicine, Triemli Hospital, Zürich, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcmd.2014.07.017DOI Listing
January 2015

Afamelanotide (CUV1647) in dermal phototoxicity of erythropoietic protoporphyria.

Expert Rev Clin Pharmacol 2015 Jan 3;8(1):43-53. Epub 2014 Dec 3.

Institute of Laboratory Medicine, Stadtspital Triemli, CH-8063 Zürich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17512433.2014.956089DOI Listing
January 2015

Iron availability modulates aberrant splicing of ferrochelatase through the iron- and 2-oxoglutarate dependent dioxygenase Jmjd6 and U2AF(65.).

Blood Cells Mol Dis 2013 Oct 18;51(3):151-61. Epub 2013 Jun 18.

Institute of Laboratory Medicine, Stadtspital Triemli, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcmd.2013.05.008DOI Listing
October 2013

Results of a pilot external quality assessment study on free protoporphyrin in erythrocytes.

Clin Chem Lab Med 2011 Jun 17;49(6):1059-60. Epub 2011 May 17.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/CCLM.2011.177DOI Listing
June 2011

Effects of different centrifugation conditions on clinical chemistry and Immunology test results.

BMC Clin Pathol 2011 May 10;11. Epub 2011 May 10.

Stadtspital Triemli, Central laboratory Birmensdorferstrasse 497 CH-8063 Zürich Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1472-6890-11-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123263PMC
May 2011

Exacerbation of erythropoietic protoporphyria by hyperthyroidism.

J Inherit Metab Dis 2010 Dec 11;33 Suppl 3:S465-9. Epub 2010 Nov 11.

Central laboratory, Triemli Hospital, Zurich, Switzerland,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10545-010-9234-zDOI Listing
December 2010

Afamelanotide, an agonistic analog of α-melanocyte-stimulating hormone, in dermal phototoxicity of erythropoietic protoporphyria.

Expert Opin Investig Drugs 2010 Dec 13;19(12):1591-602. Epub 2010 Nov 13.

Stadtspital Triemli, Central Laboratory, Zurich, CH-8063, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2010.535515DOI Listing
December 2010

Patient-recorded outcome to assess therapeutic efficacy in protoporphyria-induced dermal phototoxicity: a proposal.

Health Qual Life Outcomes 2010 Jun 21;8:60. Epub 2010 Jun 21.

Stadtspital Triemli, Zentrallabor, Birmensdorferstrasse 497, CH-8063 Zürich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1477-7525-8-60DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905349PMC
June 2010

Mitigating photosensitivity of erythropoietic protoporphyria patients by an agonistic analog of alpha-melanocyte stimulating hormone.

Photochem Photobiol 2009 Nov-Dec;85(6):1434-9

Stadtspital Triemli, Central Laboratory, University Hospital of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1751-1097.2009.00595.xDOI Listing
January 2010

Correlation between biochemical findings, structural and enzymatic abnormalities in mutated HMBS identified in six Israeli families with acute intermittent porphyria.

Blood Cells Mol Dis 2009 Mar-Apr;42(2):167-73. Epub 2009 Jan 12.

Department of Pediatrics and Center for Applied Genomics, 1st School of Medicine, Charles University, Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S107997960800221
Publisher Site
http://dx.doi.org/10.1016/j.bcmd.2008.11.001DOI Listing
May 2009

Porphyria in Switzerland, 15 years experience.

Swiss Med Wkly 2009 Apr;139(13-14):198-206

Central Laboratory, Stadtspital Triemli, Zürich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/smw-12496DOI Listing
April 2009

Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock.

Clin Res Cardiol 2008 May 28;97(5):298-305. Epub 2007 Dec 28.

Division of Cardiology, Department of Internal Medicine , Stadtspital Triemli, Birmensdorferstrasse 497, 8063, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00392-007-0626
Web Search
http://link.springer.com/10.1007/s00392-007-0626-5
Publisher Site
http://dx.doi.org/10.1007/s00392-007-0626-5DOI Listing
May 2008

Swiss patients with variegate porphyria have unique mutations.

Swiss Med Wkly 2006 Aug;136(31-32):515-9

Zentrallabor, Stadtspital Triemli, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/2006/31/smw-11472DOI Listing
August 2006

A "null allele" mutation is responsible for erythropoietic protoporphyria in an Israeli patient who underwent liver transplantation: relationships among biochemical, clinical, and genetic parameters.

Blood Cells Mol Dis 2003 May-Jun;30(3):298-301

Porphyria Reference Laboratory, Rabin Medical Center, Beilinson Campus, Sackler Faculty of Medicine, Tel Aviv University, Petah-Tikva, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1079-9796(03)00040-8DOI Listing
March 2004